These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 27704357

  • 21. Acylglycerol kinase functions as an oncogene and an unfavorable prognostic marker of human gliomas.
    Liu N, Wang Z, Cheng Y, Zhang P, Wang X, Yang H, Liu H, Zhang Y, Tu Y.
    Hum Pathol; 2016 Dec; 58():105-112. PubMed ID: 27574811
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide.
    Redjal N, Reinshagen C, Le A, Walcott BP, McDonnell E, Dietrich J, Nahed BV.
    J Neurooncol; 2016 May; 127(3):505-14. PubMed ID: 26830093
    [Abstract] [Full Text] [Related]

  • 27. Dec1 expression predicts prognosis and the response to temozolomide chemotherapy in patients with glioma.
    Li XM, Lin W, Wang J, Zhang W, Yin AA, Huang Y, Zhang J, Yao L, Bian H, Zhang J, Zhang X.
    Mol Med Rep; 2016 Dec; 14(6):5626-5636. PubMed ID: 27840944
    [Abstract] [Full Text] [Related]

  • 28. Is the absolute value of O(6)-methylguanine-DNA methyltransferase gene messenger RNA a prognostic factor, and does it predict the results of treatment of glioblastoma with temozolomide?
    Tanaka S, Akimoto J, Narita Y, Oka H, Tashiro T.
    J Neurosurg; 2014 Oct; 121(4):818-26. PubMed ID: 25105699
    [Abstract] [Full Text] [Related]

  • 29. A Novel Tumor-Suppressor, CDH18, Inhibits Glioma Cell Invasiveness Via UQCRC2 and Correlates with the Prognosis of Glioma Patients.
    Bai YH, Zhan YB, Yu B, Wang WW, Wang L, Zhou JQ, Chen RK, Zhang FJ, Zhao XW, Duan WC, Wang YM, Liu J, Bao JJ, Zhang ZY, Liu XZ.
    Cell Physiol Biochem; 2018 Oct; 48(4):1755-1770. PubMed ID: 30078018
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H, Yu L, Liu J, Bian X, Shi C, Sun C, Zhou X, Wen Y, Hua D, Zhao S, Ren L, An T, Luo W, Wang Q, Yu S.
    Oncotarget; 2017 Mar 21; 8(12):19723-19737. PubMed ID: 28160566
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Slit2 and Robo1 expression as biomarkers for assessing prognosis in brain glioma patients.
    Liu L, Li W, Geng S, Fang Y, Sun Z, Hu H, Liang Z, Yan Z.
    Surg Oncol; 2016 Dec 21; 25(4):405-410. PubMed ID: 27916173
    [Abstract] [Full Text] [Related]

  • 35. Prognostic significance of CDC25B expression in gliomas.
    Nakabayashi H, Hara M, Shimizu K.
    J Clin Pathol; 2006 Jul 21; 59(7):725-8. PubMed ID: 16803948
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas.
    Wu X, Wu F, Xu D, Zhang T.
    J Neurooncol; 2016 Apr 21; 127(2):221-32. PubMed ID: 26757925
    [Abstract] [Full Text] [Related]

  • 38. High expression of RAB43 predicts poor prognosis and is associated with epithelial-mesenchymal transition in gliomas.
    Han MZ, Huang B, Chen AJ, Zhang X, Xu R, Wang J, Li XG.
    Oncol Rep; 2017 Feb 21; 37(2):903-912. PubMed ID: 28075478
    [Abstract] [Full Text] [Related]

  • 39. Sunitinib Malate plus Lomustine for Patients with Temozolomide-refractory Recurrent Anaplastic or Low-grade Glioma.
    Duerinck J, Du Four S, Sander W, Van Binst AM, Everaert H, Michotte A, Hau P, Neyns B.
    Anticancer Res; 2015 Oct 21; 35(10):5551-7. PubMed ID: 26408725
    [Abstract] [Full Text] [Related]

  • 40. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
    Hueng DY, Tsai WC, Chiou HY, Feng SW, Lin C, Li YF, Huang LC, Lin MH.
    Int J Mol Sci; 2015 Jul 09; 16(7):15578-91. PubMed ID: 26184164
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.